Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer

被引：0
|
作者：
Michel L. Peters
Claudine de Meijer
Dirk Wyndaele
Walter Noordzij
Annemarie M. Leliveld-Kors
Joan van den Bosch
Pieter H. van den Berg
Agni Baka
Jennifer G. Gaultney
机构：
[1] Real World Strategy and Analytics,Department of Nuclear Medicine
[2] Mapi Group,Department of Nuclear Medicine and Molecular Imaging
[3] Bayer B.V.,Department of Urology
[4] Catharina Ziekenhuis,Department of Internal Medicine
[5] University of Groningen,Department of Internal Medicine
[6] University Medical Centre Groningen,undefined
[7] University of Groningen,undefined
[8] University Medical Centre Groningen,undefined
[9] Albert Schweitzer Ziekenhuis,undefined
[10] Tergooi Ziekenhuizen,undefined
[11] Real World Strategy and Analytics,undefined
[12] Mapi Group,undefined
来源：
Applied Health Economics and Health Policy | 2018年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The article Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer, written by Michel L. Peters, Claudine de Meijer, Dirk Wyndaele, Walter Noordzij, Annemarie M. Leliveld-Kors, Joan van den Bosch, Pieter H. van den Berg, Agni Baka, Jennifer G. Gaultney was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 2nd September, 2017 without open access.
引用
收藏
页码：145 / 145
相关论文
共 50 条
  • [21] EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer
    Thorsten D. Poeppel
    Daria Handkiewicz-Junak
    Michael Andreeff
    Alexander Becherer
    Andreas Bockisch
    Eva Fricke
    Lilli Geworski
    Alexander Heinzel
    Bernd J. Krause
    Thomas Krause
    Markus Mitterhauser
    Wilfried Sonnenschein
    Lisa Bodei
    Roberto C. Delgado-Bolton
    Michael Gabriel
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 824 - 845
  • [22] Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
    Vidal, Monica
    Delgado, Alejandro
    Martinez, Carlos
    Jaime Correa, Jose
    Cristina Durango, Isabel
    [J]. INTERNATIONAL BRAZ J UROL, 2020, 46 (04): : 599 - 611
  • [23] Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
    Saylor, Philip J.
    Otani, Keisuke
    Balza, Rene
    Ukleja, Jacob
    Pleskow, Haley
    Fisher, Rebecca
    Kusaka, Erika
    Otani, Yukako S.
    Badusi, Priscilla Oluwakemi
    Smith, Matthew R.
    Meneely, Erika
    Olivier, Kara
    Lowe, Alarice C.
    Toner, Mehmet
    Maheswaran, Shyamala
    Haber, Daniel A.
    Yeap, Beow Y.
    Lee, Richard J.
    Miyamoto, David T.
    [J]. JCO PRECISION ONCOLOGY, 2024, 8
  • [24] Selection and monitoring of patients with metastatic castration-resistant prostate cancer for treatment with radium-223
    Rodriguez-Vida, A.
    Torregrosa, M. D.
    Pinto, A.
    Climent, M. A.
    Olmos, D.
    Carles, J.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (06): : 679 - 686
  • [25] A Case of Success: Complete Response to Radium-223 in Metastatic Castration-Resistant Prostate Cancer
    Pinho, Ines Soares de
    Esperanca-Martins, Miguel
    Machado, Barbara
    Damaso, Sara
    Bras, Raquel Lopes
    Cantinho, Guilhermina
    Fernandes, Isabel
    Costa, Luis
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [26] EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer
    Poeppel, Thorsten D.
    Handkiewicz-Junak, Daria
    Andreeff, Michael
    Becherer, Alexander
    Bockisch, Andreas
    Fricke, Eva
    Geworski, Lilli
    Heinzel, Alexander
    Krause, Bernd J.
    Krause, Thomas
    Mitterhauser, Markus
    Sonnenschein, Wilfried
    Bodei, Lisa
    Delgado-Bolton, Roberto C.
    Gabriel, Michael
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (05) : 824 - 845
  • [27] Predictors for Survival After Radium-223 Treatment for Castration-Resistant Metastatic Prostate Cancer
    Anderson, E.
    Wong, W. W.
    Mohammadi, H.
    Daniels, T. B.
    Vora, S.
    Schild, S. E.
    Keole, S. R.
    Choo, C. R.
    Tzou, K. S.
    Bryce, A.
    Ho, T. H.
    Quevedo, F. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E255 - E255
  • [28] Radium-223 plus abiraterone in metastatic castration-resistant prostate cancer: a cautionary tale
    Sedhom, Ramy
    Antonarakis, Emmanuel S.
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 : S341 - S345
  • [29] Selection and monitoring of patients with metastatic castration-resistant prostate cancer for treatment with radium-223
    A. Rodriguez-Vida
    M. D. Torregrosa
    Á. Pinto
    M. Á. Climent
    D. Olmos
    J. Carles
    [J]. Clinical and Translational Oncology, 2018, 20 : 679 - 686
  • [30] Radium-223: Insight and Perspectives in Bone-metastatic Castration-resistant Prostate Cancer
    Buroni, Federica Eleonora
    Persico, Marco Giovanni
    Pasi, Francesca
    Lodola, Lorenzo
    Nano, Rosanna
    Aprile, Carlo
    [J]. ANTICANCER RESEARCH, 2016, 36 (11) : 5719 - 5730
12345